← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 1999Last known activity
Oct 20, 2021
Acquired by Seattle Genetics → Pfizer on Mar 9, 2018
Timeline
1980s
- Jun 1, 1985
Cascadian Therapeutics Inc.— Founded
2010s
- Mar 9, 2018
Seattle Genetics— Acquired By
2020s
- Mar 13, 2023
Pfizer— Now
Drugs by trial phase (18 distinct, 22 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Glioblastoma
- Lymphoma
- Melanoma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Prostatic Neoplasms
- Squamous Cell Carcinoma of Head and Neck
Recent trials (29)
- NCT03424473Lead sponsorN/A—
- NCT05070702Lead sponsorPhase 1Oct 20, 2021
- NCT03758339Lead sponsorPhase 1Dec 30, 2017
- NCT03758339Study directorPhase 1Dec 30, 2017
- NCT03043313CollaboratorPhase 2Jun 23, 2017
- NCT02614794Study directorPhase 2Dec 1, 2015
- NCT02614794Lead sponsorPhase 2Dec 1, 2015
- NCT02270372Lead sponsorPhase 1Nov 1, 2014
- NCT01983501Lead sponsorPhase 1Feb 1, 2014
- NCT01983501Study directorPhase 1Feb 1, 2014
- NCT02025192Lead sponsorPhase 1Dec 1, 2013
- NCT02025192Study directorPhase 1Dec 1, 2013
- NCT01556789Lead sponsorPhase 1Mar 1, 2013
- NCT01556789Study chairPhase 1Mar 1, 2013
- NCT01978964Lead sponsorPhase 1Nov 1, 2012
Details
- Founded
- Seattle, WA, US Jun 1, 1985
- Last known activity
- Oct 20, 2021